Key facts
- This page summarizes Kyle Fletcher's Form 4 filing for Celularity Inc (CELU).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Feb 2024, 21:10.
Kyle Fletcher - 16 Feb 2024 Form 4 Insider Report for Celularity Inc (CELU)
- Reporting relationship
- Executive Vice President, General Counsel
- Issuer ticker
- CELU
- Reported as of
- 16 Feb 2024
- Net transaction value
- -$17,174
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2024, 21:10:27 UTC
- Prior SEC filing
- 17 Apr 2023
- Next SEC filing
- 19 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kyle Fletcher
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kyle Fletcher filed Form 4 for Celularity Inc (CELU) on 21 Feb 2024.
Change
- Previous filing in this sequence was filed on 17 Apr 2023.
- Current net transaction value: -$17,174.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CELU
transaction
Class A Common Stock
Tax liability
- Transaction value
- $17,174
- Shares
- -39,571
- Change %
- -15%
- Price
- $0.4340
- Shares after
- 217,228
- Date
- 17 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CELU
transaction
Derivative
Stock Option Grant (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +164,171
- Change %
- Price
- $0.000000
- Shares after
- 164,171
- Date
- 16 Feb 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 164,171
- Exercise price
- $0.4340
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan") and does not represent a sale.
Footnote F2
Includes 209,891 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
Footnote F3
The option was granted pursuant to the 2021 Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date.
SEC remarks
Executive Vice President, General Counsel